| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Body weight and sensitivity of screening mammography
|
Njor, Sisse H.
|
|
2016
|
60 |
C |
p. 93-100
8 p.
|
artikel
|
| 2 |
CD66 and CD49f expressing cells are associated with distinct neoplastic phenotypes and progression in human cervical cancer
|
Ammothumkandy, Aswathy
|
|
2016
|
60 |
C |
p. 166-178
13 p.
|
artikel
|
| 3 |
CD103 defines intraepithelial CD8+ PD1+ tumour-infiltrating lymphocytes of prognostic significance in endometrial adenocarcinoma
|
Workel, Hagma H.
|
|
2016
|
60 |
C |
p. 1-11
11 p.
|
artikel
|
| 4 |
Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor
|
Belum, V.R.
|
|
2016
|
60 |
C |
p. 12-25
14 p.
|
artikel
|
| 5 |
Combination of bendamustine and rituximab as front-line therapy for patients with chronic lymphocytic leukaemia: multicenter, retrospective clinical practice experience with 279 cases outside of controlled clinical trials
|
Gentile, Massimo
|
|
2016
|
60 |
C |
p. 154-165
12 p.
|
artikel
|
| 6 |
Corrigendum to “Genetic heterogeneity after first-line chemotherapy in high-grade serous ovarian cancer” [Eur J Cancer 53 (2016) 51–64]
|
Lambrechts, Sandrina
|
|
2016
|
60 |
C |
p. 226-
1 p.
|
artikel
|
| 7 |
Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy
|
Hofmann, Lars
|
|
2016
|
60 |
C |
p. 190-209
20 p.
|
artikel
|
| 8 |
Development of molecularly targeted agents and immunotherapies in small cell lung cancer
|
Sharp, Adam
|
|
2016
|
60 |
C |
p. 26-39
14 p.
|
artikel
|
| 9 |
Effect of neoadjuvant chemotherapy on breast cancer phenotype, ER/PR and HER2 expression – Implications for the practising oncologist
|
Gahlaut, Renu
|
|
2016
|
60 |
C |
p. 40-48
9 p.
|
artikel
|
| 10 |
Elderly ovarian cancer patients: An individual participant data meta-analysis of the North-Eastern German Society of Gynecological Oncology (NOGGO)
|
Woopen, H.
|
|
2016
|
60 |
C |
p. 101-106
6 p.
|
artikel
|
| 11 |
Epirubicin dose and sequential hormonal therapy—Mature results of the HMFEC randomised phase III trial in premenopausal patients with node positive early breast cancer
|
Coombes, R.C.
|
|
2016
|
60 |
C |
p. 146-153
8 p.
|
artikel
|
| 12 |
High co-expression of PD-L1 and HIF-1α correlates with tumour necrosis in pulmonary pleomorphic carcinoma
|
Chang, Yih-Leong
|
|
2016
|
60 |
C |
p. 125-135
11 p.
|
artikel
|
| 13 |
Homologous recombination deficiency and ovarian cancer
|
Ledermann, Jonathan A.
|
|
2016
|
60 |
C |
p. 49-58
10 p.
|
artikel
|
| 14 |
Low awareness of risk factors among bladder cancer survivors: New evidence and a literature overview
|
Westhoff, Ellen
|
|
2016
|
60 |
C |
p. 136-145
10 p.
|
artikel
|
| 15 |
Luteal versus follicular phase surgical oophorectomy plus tamoxifen in premenopausal women with metastatic hormone receptor-positive breast cancer
|
Love, Richard R.
|
|
2016
|
60 |
C |
p. 107-116
10 p.
|
artikel
|
| 16 |
Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy
|
Zimmer, Lisa
|
|
2016
|
60 |
C |
p. 210-225
16 p.
|
artikel
|
| 17 |
Outcome of extracranial malignant rhabdoid tumours in children registered in the European Paediatric Soft Tissue Sarcoma Study Group Non-Rhabdomyosarcoma Soft Tissue Sarcoma 2005 Study—EpSSG NRSTS 2005
|
Brennan, Bernadette
|
|
2016
|
60 |
C |
p. 69-82
14 p.
|
artikel
|
| 18 |
Results of the Belgian expanded access program of eribulin in the treatment of metastatic breast cancer closely mirror those of the pivotal phase III trial
|
Aftimos, Philippe
|
|
2016
|
60 |
C |
p. 117-124
8 p.
|
artikel
|
| 19 |
The integrin-linked kinase-associated phosphatase (ILKAP) is a regulatory hub of ovarian cancer cell susceptibility to platinum drugs
|
Lorenzato, Annalisa
|
|
2016
|
60 |
C |
p. 59-68
10 p.
|
artikel
|
| 20 |
Toenail selenium status and risk of subtypes of head-neck cancer: The Netherlands Cohort Study
|
Maasland, Denise H.E.
|
|
2016
|
60 |
C |
p. 83-92
10 p.
|
artikel
|
| 21 |
Treatment patterns of advanced malignant melanoma (stage III–IV) – A review of current standards in Europe
|
Harries, Mark
|
|
2016
|
60 |
C |
p. 179-189
11 p.
|
artikel
|
Tijdschrift beschrijving